Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Q32 Bio (QTTB) EPS (Basic) (2018 - 2025)

Historic EPS (Basic) for Q32 Bio (QTTB) over the last 8 years, with Q3 2025 value amounting to -$0.6.

  • Q32 Bio's EPS (Basic) rose 5890.41% to -$0.6 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.39, marking a year-over-year increase of 9570.89%. This contributed to the annual value of -$0.01 for FY2024, which is 9999.56% up from last year.
  • Q32 Bio's EPS (Basic) amounted to -$0.6 in Q3 2025, which was up 5890.41% from -$0.78 recorded in Q2 2025.
  • In the past 5 years, Q32 Bio's EPS (Basic) ranged from a high of $5.29 in Q4 2024 and a low of -$77.15 during Q4 2023
  • Moreover, its 5-year median value for EPS (Basic) was -$0.6 (2022), whereas its average is -$8.15.
  • Per our database at Business Quant, Q32 Bio's EPS (Basic) surged by 815000.0% in 2022 and then crashed by 1275833.33% in 2023.
  • Over the past 5 years, Q32 Bio's EPS (Basic) (Quarter) stood at -$0.61 in 2021, then grew by 1.23% to -$0.6 in 2022, then tumbled by 12758.33% to -$77.15 in 2023, then skyrocketed by 106.85% to $5.29 in 2024, then tumbled by 111.35% to -$0.6 in 2025.
  • Its last three reported values are -$0.6 in Q3 2025, -$0.78 for Q2 2025, and -$0.9 during Q1 2025.